Screener
Tango Therapeutics TNGX Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Tango Therapeutics’s reported figures.
Based on trailing twelve months.
The source filing: Tango Therapeutics’s 10-Q, filed May 13, 2026. Open the filing →
- Filed
- May 13, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-221656
FAQ
- What is Tango Therapeutics's operating margin?
- Tango Therapeutics (TNGX) reported operating margin of -206.2% in Q1 2026.
- How has Tango Therapeutics's operating margin changed year-over-year?
- Tango Therapeutics's operating margin increased by 42.1% year-over-year, from -355.9% to -206.2%.
- What is the long-term trend for Tango Therapeutics's operating margin?
- Over 4 years (2021 to 2025), Tango Therapeutics's operating margin has grown at a 3.2% compound annual growth rate (CAGR), from -157.1% to -178.4%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.
Ask your AI about Tango Therapeutics's operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude